Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Pract Radiat Oncol. 2017 Nov-Dec;7(6):e419-e425. doi: 10.1016/j.prro.2017.04.016. Epub 2017 Apr 26.
Although historical trials have established the role of surgical resection followed by whole brain irradiation (WBRT) for brain metastases, WBRT has recently been shown to cause significant neurocognitive decline. Many practitioners have employed postoperative stereotactic radiosurgery (SRS) to tumor resection cavities to increase local control without causing significant neurocognitive sequelae. However, studies analyzing outcomes of large brain metastases treated with resection and postoperative SRS are lacking. Here we compare outcomes in patients with large brain metastases >4 cm to those with smaller metastases ≤4 cm treated with surgical resection followed by SRS to the resection cavity.
Consecutive patients with brain metastases treated at our institution with surgical resection and postoperative SRS were retrospectively reviewed. Patients were stratified into ≤4 cm and >4 cm cohorts based on preoperative maximal tumor dimension. Cumulative incidence of local failure, radiation necrosis, and death were analyzed for the 2 cohorts using a competing-risk model, defined as the time from SRS treatment date to the measured event, death, or last follow-up.
A total of 117 consecutive cases were identified. Of these patients, 90 (77%) had preoperative tumors ≤4 cm, and 27 (23%) >4 cm in greatest dimension. The only significant baseline difference between the 2 groups was a higher proportion of patients who underwent gross total resection in the ≤4 cm compared with the >4 cm cohort, 76% versus 48%, respectively (P <.01). The 1-year rates of local failure, radiation necrosis, and overall survival for the ≤4 cm and >4 cm cohorts were 12.3% and 16.0%, 26.9% and 28.4%, and 80.6% and 67.6%, respectively (all P >.05). The rates of local failure and radiation necrosis were not statistically different on multivariable analysis based on tumor size.
Brain metastases >4 cm in largest dimension managed by resection and radiosurgery to the tumor cavity have promising local control rates without a significant increase in radiation necrosis on our retrospective review.
虽然历史研究已经证实了手术切除联合全脑放疗(WBRT)在脑转移瘤中的作用,但最近的研究表明 WBRT 会导致显著的神经认知功能下降。许多医生已经采用术后立体定向放射外科(SRS)治疗肿瘤切除腔,以增加局部控制率,而不会引起显著的神经认知后遗症。然而,缺乏分析大的脑转移瘤切除术后行 SRS 治疗结果的研究。在此,我们比较了>4cm 和≤4cm 的大的脑转移瘤患者的治疗结果,这些患者均接受了手术切除联合术后 SRS 治疗。
对我院接受手术切除联合术后 SRS 治疗的脑转移瘤患者进行回顾性研究。根据术前最大肿瘤直径,将患者分为≤4cm 和>4cm 两组。采用竞争风险模型分析两组患者的局部失败、放射性坏死和死亡的累积发生率,定义为从 SRS 治疗日期到测量的事件、死亡或最后一次随访的时间。
共纳入 117 例连续患者。其中,90 例(77%)术前肿瘤直径≤4cm,27 例(23%)肿瘤直径>4cm。两组之间唯一显著的基线差异是,在≤4cm 组中,行完全切除的患者比例明显高于>4cm 组,分别为 76%和 48%(P<0.01)。≤4cm 和>4cm 两组的 1 年局部失败、放射性坏死和总生存率分别为 12.3%和 16.0%、26.9%和 28.4%、80.6%和 67.6%(均 P>0.05)。多变量分析显示,肿瘤大小不是局部失败和放射性坏死的统计学差异因素。
在我们的回顾性研究中,最大径>4cm 的脑转移瘤行手术切除联合肿瘤腔 SRS 治疗,局部控制率令人满意,放射性坏死发生率无显著增加。